8ML-16528-93949
4 vaccinations
3 coded responses
45 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 941 / CA
- Registered
- 2021-11-06
- Relationship
- Child or adolescent in my care
- Guardian
- 5T9-30826-02622
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Registered in v-safe
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-11-06
Health check-in — day 0, dose 1, dependentFeeling: Good · Site: Pain, Itching · NoneAdult check-in
- 2021-11-07
- 2021-11-09
- 2021-11-10
- 2021-11-12
- 2021-11-13
- 2021-11-20
- 2021-11-27
-
2021-12-02
Dose 2 — Pfizer-BioNTech
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-09
- 2021-12-16
- 2021-12-25
- 2021-12-30
- 2022-01-08
- 2022-01-13
- 2022-03-03
-
2022-05-24
Dose 3 — Pfizer-BioNTech
- 2022-05-24
-
2022-05-26
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph node underarmMedDRA releases: 2024-11 · check-in free text available
- 2022-05-27
- 2022-05-28
- 2022-05-29
- 2022-05-31
- 2022-06-09
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-07-05
- 2022-08-23
-
2022-10-28
Dose 4 — Moderna
- 2022-10-28
- 2022-10-29
- 2022-10-30
-
2022-10-31
Survey response — days 1–6 daily, dose 4, dependentMedDRA: Chalazion, Eyelid pain, Hordeolum, Swelling of eyelid — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chalazion/stye with lower eyelid swelling and painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Report sent to call center — days 1–6 daily, dose 4, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-01
- 2022-11-01
-
2022-11-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-03
- 2022-11-04
- 2022-11-11
- 2022-11-19
- 2022-11-27
-
2022-12-04
Survey response — day 35, dose 4, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
- 2023-01-27
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-02 | Pfizer-BioNTech | No |
| 3 | 2022-05-24 | Pfizer-BioNTech | No |
| 4 | 2022-10-28 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Swollen lymph node underarm
Release 12 — days 1–6 daily, dose 4, dependent
Systemic reaction (other): Chalazion/stye with lower eyelid swelling and pain
Release 12 — day 35, dose 4, dependent
Symptoms: Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Chalazion | · | · | ✓ |
| SRO | Eyelid pain | · | · | ✓ |
| SRO | Hordeolum | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Swelling of eyelid | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release